Security · CUSIP 80862K104
SCICLONE PHARMACEUTICALS INC
COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 128
Added / reduced
0 / 0
net -35.3M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q4 2017
Nothing to show.
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| BlackRock Inc. | Sold out | -7,330,329 | -100.0% |
| VANGUARD GROUP INC | Sold out | -2,972,383 | -100.0% |
| DIMENSIONAL FUND ADVISORS LP | Sold out | -2,885,725 | -100.0% |
| GLG Partners LP | Sold out | -2,586,437 | -100.0% |
| STATE STREET CORP | Sold out | -1,650,696 | -100.0% |
| AQR CAPITAL MANAGEMENT LLC | Sold out | -1,030,748 | -100.0% |
| TWO SIGMA INVESTMENTS, LP | Sold out | -846,803 | -100.0% |
| Marshall Wace North America L.P. | Sold out | -843,451 | -100.0% |
| Bank of New York Mellon Corp | Sold out | -798,073 | -100.0% |
| NORTHERN TRUST CORP | Sold out | -687,426 | -100.0% |
118 more rows. Subscribe for $29/month to see every row, download the data and use the API.